Drugs in cardiac transplantation [2]

New England Journal of Medicine

Volumn 334, Issue 6, 1996, Pages 400-402

  Ballantyne, C M ^a   Von Moltke, L L ^a   Greenblatt, D J ^a   Kobashigawa, J ^a   Keogh, A M ^a   Valantine, H A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ITRACONAZOLE; KETOCONAZOLE; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

CHOLESTEROL BLOOD LEVEL; DRUG POTENCY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MORTALITY; MYOSITIS; NATURAL KILLER CELL; PRIORITY JOURNAL; RHABDOMYOLYSIS; VASCULAR DISEASE;

ANTICHOLESTEREMIC AGENTS; ANTIFUNGAL AGENTS; CHOLESTEROL; CYCLOSPORINE; DRUG INTERACTIONS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; PRAVASTATIN;

EID: 0030028793     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199602083340613     Document Type: Letter

References (0)